A Study to Evaluate the Safety and Tolerability of Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis (RRMS) Without an Alternative Therapeutic Option.
Phase of Trial: Phase II
Latest Information Update: 04 Dec 2015
At a glance
- Drugs Fingolimod (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions
- 04 Dec 2015 New trial record